Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 20% ± 5% | |
epithelial cell | 6 studies | 29% ± 13% | |
goblet cell | 4 studies | 22% ± 3% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 27% ± 6% | |
myeloid cell | 3 studies | 19% ± 4% | |
ciliated cell | 3 studies | 22% ± 4% | |
macrophage | 3 studies | 19% ± 4% | |
dendritic cell | 3 studies | 33% ± 22% | |
basal cell | 3 studies | 25% ± 6% | |
transit amplifying cell | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6818.33 | 1445 / 1445 | 100% | 34.71 | 183 / 183 |
prostate | 100% | 7140.12 | 245 / 245 | 100% | 51.52 | 502 / 502 |
lung | 100% | 7586.43 | 578 / 578 | 100% | 36.49 | 1154 / 1155 |
breast | 100% | 6489.62 | 459 / 459 | 100% | 46.44 | 1116 / 1118 |
skin | 100% | 5414.12 | 1809 / 1809 | 100% | 49.59 | 471 / 472 |
uterus | 100% | 5821.81 | 170 / 170 | 100% | 33.34 | 458 / 459 |
thymus | 100% | 6219.75 | 653 / 653 | 100% | 33.66 | 603 / 605 |
stomach | 100% | 6073.97 | 359 / 359 | 100% | 32.08 | 285 / 286 |
brain | 100% | 3695.45 | 2633 / 2642 | 100% | 35.13 | 704 / 705 |
ovary | 100% | 4639.57 | 180 / 180 | 99% | 36.71 | 427 / 430 |
intestine | 100% | 6928.69 | 966 / 966 | 99% | 34.55 | 523 / 527 |
bladder | 100% | 6964.29 | 21 / 21 | 99% | 33.55 | 499 / 504 |
pancreas | 100% | 4346.54 | 328 / 328 | 99% | 32.33 | 176 / 178 |
kidney | 100% | 4685.10 | 89 / 89 | 98% | 23.84 | 882 / 901 |
adrenal gland | 100% | 9660.91 | 258 / 258 | 97% | 31.08 | 222 / 230 |
liver | 100% | 4870.48 | 226 / 226 | 90% | 16.03 | 366 / 406 |
adipose | 100% | 6616.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7520.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 44.62 | 80 / 80 |
spleen | 100% | 6844.57 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.73 | 1 / 1 |
muscle | 100% | 3249.32 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 4919.69 | 853 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 28.33 | 44 / 45 |
peripheral blood | 97% | 4127.55 | 899 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 22.59 | 28 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006954 | Biological process | inflammatory response |
GO_0008283 | Biological process | cell population proliferation |
GO_0016242 | Biological process | negative regulation of macroautophagy |
GO_0051247 | Biological process | positive regulation of protein metabolic process |
GO_0070141 | Biological process | response to UV-A |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0160049 | Biological process | negative regulation of cGAS/STING signaling pathway |
GO_0034405 | Biological process | response to fluid shear stress |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_2000010 | Biological process | positive regulation of protein localization to cell surface |
GO_0097011 | Biological process | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030334 | Biological process | regulation of cell migration |
GO_0072655 | Biological process | establishment of protein localization to mitochondrion |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0097194 | Biological process | execution phase of apoptosis |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0038061 | Biological process | non-canonical NF-kappaB signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0006979 | Biological process | response to oxidative stress |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0006006 | Biological process | glucose metabolic process |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_1990418 | Biological process | response to insulin-like growth factor stimulus |
GO_0031999 | Biological process | negative regulation of fatty acid beta-oxidation |
GO_0031641 | Biological process | regulation of myelination |
GO_0009408 | Biological process | response to heat |
GO_0010748 | Biological process | negative regulation of long-chain fatty acid import across plasma membrane |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0007165 | Biological process | signal transduction |
GO_0010761 | Biological process | fibroblast migration |
GO_0010763 | Biological process | positive regulation of fibroblast migration |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0031295 | Biological process | T cell costimulation |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0060416 | Biological process | response to growth hormone |
GO_0003376 | Biological process | sphingosine-1-phosphate receptor signaling pathway |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0010765 | Biological process | positive regulation of sodium ion transport |
GO_0060716 | Biological process | labyrinthine layer blood vessel development |
GO_0006809 | Biological process | nitric oxide biosynthetic process |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0006606 | Biological process | protein import into nucleus |
GO_0060644 | Biological process | mammary gland epithelial cell differentiation |
GO_0010907 | Biological process | positive regulation of glucose metabolic process |
GO_0010975 | Biological process | regulation of neuron projection development |
GO_0032079 | Biological process | positive regulation of endodeoxyribonuclease activity |
GO_0010467 | Biological process | gene expression |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0045746 | Biological process | negative regulation of Notch signaling pathway |
GO_0150033 | Biological process | negative regulation of protein localization to lysosome |
GO_0070848 | Biological process | response to growth factor |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0071380 | Biological process | cellular response to prostaglandin E stimulus |
GO_0001893 | Biological process | maternal placenta development |
GO_0016567 | Biological process | protein ubiquitination |
GO_2000074 | Biological process | regulation of type B pancreatic cell development |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0005979 | Biological process | regulation of glycogen biosynthetic process |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0090201 | Biological process | negative regulation of release of cytochrome c from mitochondria |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0051146 | Biological process | striated muscle cell differentiation |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_1990090 | Biological process | cellular response to nerve growth factor stimulus |
GO_1903721 | Biological process | positive regulation of I-kappaB phosphorylation |
GO_0016310 | Biological process | phosphorylation |
GO_0019049 | Biological process | virus-mediated perturbation of host defense response |
GO_0048266 | Biological process | behavioral response to pain |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0046622 | Biological process | positive regulation of organ growth |
GO_0140052 | Biological process | cellular response to oxidised low-density lipoprotein particle stimulus |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071901 | Biological process | negative regulation of protein serine/threonine kinase activity |
GO_1901653 | Biological process | cellular response to peptide |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_1902018 | Biological process | negative regulation of cilium assembly |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0042593 | Biological process | glucose homeostasis |
GO_0043488 | Biological process | regulation of mRNA stability |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_2000402 | Biological process | negative regulation of lymphocyte migration |
GO_1905552 | Biological process | positive regulation of protein localization to endoplasmic reticulum |
GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0031929 | Biological process | TOR signaling |
GO_0043276 | Biological process | anoikis |
GO_0045737 | Biological process | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_1902176 | Biological process | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
GO_0022605 | Biological process | mammalian oogenesis stage |
GO_0036294 | Biological process | cellular response to decreased oxygen levels |
GO_0045725 | Biological process | positive regulation of glycogen biosynthetic process |
GO_0006417 | Biological process | regulation of translation |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0110002 | Biological process | regulation of tRNA methylation |
GO_0008637 | Biological process | apoptotic mitochondrial changes |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0032287 | Biological process | peripheral nervous system myelin maintenance |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0072656 | Biological process | maintenance of protein location in mitochondrion |
GO_0030154 | Biological process | cell differentiation |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0006924 | Biological process | activation-induced cell death of T cells |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0035655 | Biological process | interleukin-18-mediated signaling pathway |
GO_2001240 | Biological process | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0051000 | Biological process | positive regulation of nitric-oxide synthase activity |
GO_1903038 | Biological process | negative regulation of leukocyte cell-cell adhesion |
GO_0032094 | Biological process | response to food |
GO_1900182 | Biological process | positive regulation of protein localization to nucleus |
GO_0099175 | Biological process | regulation of postsynapse organization |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098794 | Cellular component | postsynapse |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0031982 | Cellular component | vesicle |
GO_0005819 | Cellular component | spindle |
GO_0030291 | Molecular function | protein serine/threonine kinase inhibitor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0030235 | Molecular function | nitric-oxide synthase regulator activity |
GO_0099104 | Molecular function | potassium channel activator activity |
GO_0016301 | Molecular function | kinase activity |
Gene name | AKT1 |
Protein name | Serine-threonine protein kinase V-akt murine thymoma viral oncogene-like protein 1 isoform 2 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) AKT1m transcript variant 3 non-specific serine/threonine protein kinase (EC 2.7.11.1) AKT serine/threonine kinase 1 AKT1m transcript variant 1 (AKT1m transcript variant 2) (AKT1m transcript variant 4) RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha) |
Synonyms | PKB hCG_96740 RAC |
Description | FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis . This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates . Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported . AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport . AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) . Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis . AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 . Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 . AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization . In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' . FOXO3 and FOXO4 are phosphorylated on equivalent sites . AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) . The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 . AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I) . AKT mediates the antiapoptotic effects of IGF-I (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly . May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 . Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation . Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation . Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity . Phosphorylation of BAD stimulates its pro-apoptotic activity . Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 . Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility . Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation . Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization . These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation . Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation . Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor . Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity . Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity . In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling . . |
Accessions | ENST00000555458.6 B0LPE5 ENST00000554581.5 [P31749-1] ENST00000555528.5 [P31749-1] G3V3X1 ENST00000407796.7 [P31749-1] X2CVF3 ENST00000349310.7 [P31749-1] A0A087WY56 ENST00000402615.6 [P31749-1] A0A142IKA9 ENST00000554585.6 ENST00000553797.2 ENST00000683722.1 [P31749-1] P31749 ENST00000649815.2 [P31749-1] X2CV47 A0A0S2Z3D6 ENST00000554848.5 [P31749-1] ENST00000554192.6 G3V2I6 A0A804HJM6 |